- Report
- May 2024
- 94 Pages
Asia Pacific
From €3073EUR$3,450USD£2,674GBP
- Report
- May 2023
- 117 Pages
Global
From €3500EUR$4,209USD£3,152GBP
- Report
- July 2024
- 101 Pages
Global
From €3500EUR$4,209USD£3,152GBP
- Report
- April 2023
- 117 Pages
Global
From €3500EUR$4,209USD£3,152GBP
- Report
- November 2022
- 120 Pages
Global
From €3500EUR$4,209USD£3,152GBP
From €1648EUR$1,850USD£1,434GBP
- Report
- June 2025
Europe, Spain, Italy, ... Europe, Spain, Italy, Germany, France
From €1113EUR$1,250USD£969GBP
- Report
- June 2025
United States
From €846EUR$950USD£736GBP
- Report
- June 2025
United Kingdom
From €846EUR$950USD£736GBP
From €846EUR$950USD£736GBP
From €846EUR$950USD£736GBP
- Report
- June 2025
Germany
From €846EUR$950USD£736GBP
- Report
- June 2025
France
From €846EUR$950USD£736GBP
- Report
- January 2022
China
From €2182EUR$2,450USD£1,899GBP
From €2182EUR$2,450USD£1,899GBP

The Blood Analyzer market is a segment of the Diagnostics industry that focuses on the analysis of blood samples. Blood Analyzers are used to detect and measure a variety of substances in the blood, such as hormones, proteins, enzymes, and other metabolites. These devices are used in a variety of clinical settings, including hospitals, laboratories, and physician offices. Blood Analyzers are used to diagnose and monitor a wide range of medical conditions, including diabetes, anemia, and infectious diseases.
Blood Analyzers are typically classified into two categories: automated and manual. Automated analyzers are computer-controlled systems that can process multiple samples simultaneously. Manual analyzers are typically used for smaller sample sizes and require manual operation.
The Blood Analyzer market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, and Sysmex Corporation. Show Less Read more